Senior Vice President
Tue, Jun 15, 2021
Jun 15
exercised or converted securities in APLS
4,000 shares @ $0.00
Decreased holdings by -8.30%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology